Assessment of the Glucose Management Indicator Using Different Sampling Durations

• DOI: 10.1089/dia.2022.0284
• Publication Date: 2022-09-21T19:38:50Z
• Authors: Ryan Bailey; Peter Calhoun; Richard M. Bergen...; Roy W. Beck
• Keywords: Blood Glucose; 03 medical and health sciences; Glucose; Diabetes Mellitus, Type 1; 0302 clinical medicine; Diabetes Mellitus, Type 2; Blood Glucose Self-Monitoring; Humans

We compared the glucose management indicator (GMI) calculated using 14 days of continuous monitor (CGM) data with GMI <14 days. Analysis included 581 individuals type 1 diabetes or 2 from five clinical trials. The correlation between 14- and 7-day was 0.95 versus 10, 5, 3 0.98, 0.91, 0.86, respectively. percentages values within 0.3% 14-day were 98% 10-day GMI, 87% 77% 5-day 60% 3-day GMI. Minimal differences observed computed 7 Although 10-14 CGM are preferred for computing most patients a satisfactory estimate HbA1c can be obtained data.